First-pass extracted concept

cutaneous T-cell lymphoma

Candidate: concept label1 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

CTCL

Evidence Snippets

The roles of ICOS and ICOSL in cutaneous T-cell lymphoma (CTCL) are unclear. In this study, we examined the roles of ICOS and ICOSL in CTCL.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1disease severity associationsupports2026Source 1DOI PubMed

Upregulated ICOS and ICOSL expression reflects CTCL disease severity.

Quoted textsource-backed

the upregulated expression of ICOS and ICOSL reflected disease severity

Claim 2expression associationsupports2026Source 1DOI PubMed

CTCL tumor cells co-express ICOS and ICOSL.

Quoted textsource-backed

The tumor cells co-expressed ICOS and ICOSL

Claim 3pathogenesis rolesupports2026Source 1DOI PubMed

The ICOS-ICOSL axis plays an essential role in CTCL pathogenesis and is a potential therapeutic target.

Quoted textsource-backed

These results suggest that the ICOS-ICOSL axis plays an essential role in CTCL pathogenesis, and targeting the ICOS-ICOSL axis could be a viable strategy for treating CTCL.